Table 2.
Classification performance between clinical subgroups in individual-specific/atlas-based functional connectivity.
| SVM Classification | AUC | ACC | SEN | SPE | ||
|---|---|---|---|---|---|---|
| APOE ε4 carriers (N = 120) | Individual-specific FC | NA vs. MCI | 0.94 | 0.88 | 0.92 | 0.85 |
| MCI vs. AD | 0.92 | 0.87 | 0.73 | 0.94 | ||
| NA vs. AD | 0.94 | 0.90 | 0.92 | 0.85 | ||
| Atlas-based FC | NA vs. MCI | 0.90 | 0.82 | 0.94 | 0.65 | |
| MCI vs. AD | 0.86 | 0.75 | 0.70 | 0.80 | ||
| NA vs. AD | 0.92 | 0.88 | 0.90 | 0.80 | ||
| APOE ε4 noncarriers (N = 115) | Individual-specific FC | NA vs. MCI | 0.92 | 0.84 | 0.98 | 0.64 |
| MCI vs. AD | 0.89 | 0.81 | 0.50 | 1.00 | ||
| NA vs. AD | 0.96 | 0.89 | 0.94 | 0.82 | ||
| Atlas-based FC | NA vs. MCI | 0.90 | 0.83 | 0.96 | 0.64 | |
| MCI vs. AD | 0.89 | 0.81 | 0.50 | 1.00 | ||
| NA vs. AD | 0.96 | 0.87 | 0.94 | 0.78 |
Individual-specific FC Individual-specific functional connectivity, Atlas-based FC Atlas-based functional connectivity.